Xact Kapitalforvaltning’s bluebird bio BLUE Stock Holding History

Xact Kapitalforvaltning’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$319K	Hold	535	–	–	0.01%	974
2019 Q4	$608K	Hold	535	–	–	0.01%	853
2019 Q3	$636K	Sell	535 -124	-19%	-$189K	0.01%	786
2019 Q2	$1.08M	Hold	659	–	–	0.02%	554
2019 Q1	$1.34M	Sell	659 -54	-8%	-$95.1K	0.03%	481
2018 Q4	$916K	Buy	713 +47	+7%	+$72.1K	0.02%	577
2018 Q3	$1.26M	Buy	666 +100	+18%	+$207K	0.03%	525
2018 Q2	$1.15M	Buy	566 +62	+12%	+$141K	0.02%	546
2018 Q1	$1.11M	Buy	504 +154	+44%	+$392K	0.03%	538
2017 Q4	$807K	Buy	+350	New	+$711K	0.02%	568

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Xact Kapitalforvaltning's BLUE Position: Q1 2020 in Review

Xact Kapitalforvaltning held its bluebird bio (BLUE) position steady in Q1 2020 at 535 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #974.

Xact Kapitalforvaltning first reported a position in BLUE in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.34M in Q1 2019. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

Xact Kapitalforvaltning held 535 shares of bluebird bio worth $319K as of Q1 2020.
Xact Kapitalforvaltning left its bluebird bio share count unchanged in Q1 2020.
bluebird bio made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #974 holding.
Xact Kapitalforvaltning first reported a position in bluebird bio in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's bluebird bio position peaked at $1.34M in Q1 2019.
247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.